Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

SOP for Wet Granulation Process in Solid Dose Manufacturing

Posted on November 25, 2025November 25, 2025 By digi


SOP for Wet Granulation Process in Solid Dose Manufacturing

Step-by-Step Guide: Wet Granulation SOP in Solid Dose Manufacturing

The wet granulation process is a critical unit operation in the manufacture of solid oral dosage forms. This wet granulation SOP tutorial provides a comprehensive, stepwise approach to ensure compliance with Good Manufacturing Practice (GMP) regulations in the US, UK, and EU pharmaceutical sectors. The guide covers essential granulation parameters, robust process controls, and obligatory moisture checks, ensuring batch-to-batch consistency and product quality.

Introduction to Wet Granulation and Its GMP Significance

Wet granulation is a commonly applied technique in production of tablets and capsules, where powders are processed to form granules using a liquid binder. This technique improves flow properties, enhances compressibility, and reduces dust formation, thereby positively impacting downstream processing. Because it involves multiple critical steps, strict adherence to a documented wet granulation SOP is essential to maintain process integrity, traceability, and compliance with regulatory expectations from agencies such as the FDA, EMA, MHRA, and PIC/S.

In compliance with 21 CFR Part 211 and the EU GMP Annex 15, the process must be validated and controlled with defined granulation parameters, meticulous process controls, and validated testing methods such as moisture checks. Proper documentation, including batch records and deviations, is mandatory for regulatory audit readiness.

Step 1: Preparation and Pre-Operational Activities

Beginning the wet granulation process requires thorough preparation to prevent cross-contamination, ensure equipment readiness, and maintain personnel hygiene compliant with GMP standards.

1.1 Document Review and Material Verification

  • Verify raw material certificates of analysis (CoAs) and ensure compliance with product specifications.
  • Confirm that the batch record for the wet granulation SOP is available and complete.
  • Check that all reagents, solvents, and binder solutions are appropriately prepared as per validated formulations.
Also Read:  Bridging Formulation Changes: GMP for Dosage-Form Comparability Protocols

1.2 Equipment and Facility Preparation

  • Clean and sanitize the granulator, mixers, and related equipment following validated cleaning SOPs.
  • Ensure that equipment calibration and qualification status are current.
  • Set up environmental controls to maintain appropriate temperature and humidity within the granulation suite to meet process requirements and minimize risk of product degradation.

1.3 Personnel Training and Gowning

  • Confirm the operators have completed required training on the SOP and GMP principles.
  • Implement gowning procedures that prevent contamination and comply with cleanroom standards, particularly in EU Annex 1 environments.

Step 2: Wet Granulation Process Execution

The execution phase covers mixing of powders, binder addition, granulation, drying, and sizing, conducted in a controlled and reproducible manner.

2.1 Weighing and Premixing

  • Accurately weigh raw materials using calibrated balances, documenting all results in batch records.
  • Premix powders to achieve homogeneity before binder addition, controlling key granulation parameters such as mixing speed and time.

2.2 Binder Preparation and Addition

  • Prepare binder solutions following validated preparation SOPs, ensuring concentration and pH are within specification.
  • Add binder to the powder mass gradually to obtain optimal wet mass consistency, controlling the binder quantity (water content) as a critical process control.
  • Monitor granulation endpoints visually and via torque or power consumption metrics, which serve as in-process control indicators.

2.3 Wet Massing and Granule Formation

  • Continue mixing to ensure uniform distribution of the binder and formation of granules with desired size and density.
  • Control the granulation time and mixing speed, documented as part of the granulation parameters, to prevent over- or under-granulation.
  • Sampling the wet granules may be necessary to verify consistency and detect off-spec batches early.

2.4 Drying of Wet Granules

  • Transfer wet granules to the dryer, such as a fluid bed dryer or tray dryer, maintaining validated equipment settings for temperature, airflow, and drying time.
  • Carry out routine moisture checks using validated methods (e.g., loss on drying, Karl Fischer titration) until desired residual moisture content is achieved.
  • In-process controls during drying help to maintain granule quality and stability as expected by regulatory agencies.
Also Read:  Tablet Manufacturing GMP: Controlling Granulation, Compression and Coating Defects

2.5 Milling and Sieving

  • Once dry, mill the granules to the required size distribution, controlling mill settings (speed, screen size) that form part of the granulation parameters.
  • Carry out sieving to remove oversized particles and ensure batch uniformity.
  • Conduct particle size analysis post-processing to confirm compliance with specifications.

Step 3: In-Process Controls (IPCs) and Quality Checks

Robust process controls and quality assurance measures are essential to ensure that the wet granulation process produces consistent and compliant batches.

3.1 Monitoring Critical Granulation Parameters

  • Track binder addition rate, granulation time, mixer speed, and temperature throughout the process using automated controls or manual recording.
  • Establish alarm triggers or hold points for deviations or out-of-range values.

3.2 Moisture Content Verification

  • Perform moisture checks at critical stages: after wet massing and post-drying, employing validated analytical methods.
  • Document moisture results in batch records; reject or reprocess batches failing to meet moisture specifications.

3.3 Granule Size and Appearance Assessment

  • Regularly evaluate the granulation endpoint to ensure granules exhibit the desired size distribution, flowability, and compressibility.
  • Use sieve analysis or laser diffraction techniques as specified in the quality control plan.

3.4 Sampling and Testing for Compliance

  • Take representative in-process samples for laboratory testing and retain samples for stability and audit purposes.
  • Ensure samples are labeled, stored, and transported per GMP-compliant procedures to maintain chain of custody integrity.

Step 4: Post-Granulation Activities and Documentation

Clear documentation and proper handling after granulation are crucial to support traceability, product release, and regulatory inspections.

4.1 Equipment Cleaning and Maintenance

  • Implement validated cleaning procedures immediately after batch completion to prevent cross-contamination.
  • Record all cleaning activities in cleaning logs, including personnel involved and cleaning agents used.
  • Schedule routine maintenance and calibration as part of the equipment lifecycle management.

4.2 Batch Record Completion and Review

  • Complete batch manufacturing records (BMR) accurately, capturing all granulation parameters, process controls, deviations, and sampling results.
  • Review and approve batch documentation by qualified personnel, typically QA, before release to subsequent processing steps.
Also Read:  SOP Lifecycle Management: From Draft to Obsolete Under GMP

4.3 Handling Non-Conformances

  • Document any deviations or out-of-specification results encountered during the granulation process.
  • Initiate investigations and corrective actions per quality system procedures, ensuring full traceability and regulatory compliance.

4.4 Storage and Transfer of Granules

  • Store finished granules under controlled environmental conditions to maintain integrity until further processing.
  • Use validated containers and transport mechanisms to prevent contamination or physical property changes.

Step 5: Validation and Continuous Improvement

A robust wet granulation SOP must be supported by comprehensive process validation and ongoing monitoring to ensure it remains capable and compliant with regulatory expectations.

5.1 Process Validation

  • Conduct process validation batches covering the full range of granulation parameters to establish the design space and control strategies.
  • Document validation protocols, results, and qualification reports in accordance with ICH Q8 and Q9 guidelines.
  • Include worst-case conditions, equipment variations, and operator differences in validation studies to demonstrate process robustness.

5.2 Ongoing Process Verification (OPV)

  • Implement OPV plans incorporating periodic re-assessment of critical process controls and product quality parameters.
  • Use data trending and risk analysis tools to detect potential process drifts or deviations early.

5.3 Continuous Improvement and Change Control

  • Maintain a change control system to evaluate, approve, and document changes in the wet granulation process or materials.
  • Incorporate lessons learned and audit findings into SOP updates to enhance process performance.
  • Engage cross-functional teams from Production, QA, and Process Development to identify improvement opportunities.

In summary, strict adherence to a well-defined wet granulation SOP with vigilant monitoring of granulation parameters, thorough process controls, and accurate moisture checks is essential for compliant and efficient solid dose manufacturing. Following the outlined step-by-step tutorial ensures alignment with GMP expectations from global regulatory authorities and supports consistent product quality and patient safety.

For further comprehensive GMP guidance, pharmaceutical professionals should regularly review official documents such as the WHO Good Manufacturing Practices.

Granulation & Blending Tags:GMP, ipc, pharmasop, sop, tablets, wet granulation

Post navigation

Previous Post: SOP for Blending and Blend Uniformity Checks in Tablet Production
Next Post: SOP for Line Clearance Prior to Batch Start

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme